SCHEMBL24106466

SCHEMBL24106466

CCCC(C)Cc1cccc(Oc2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ LMNA P02545 1/20 0.49
▸ MME P08473 1/20 0.48
▸ ACE P12821 1/20 0.48
▸ CPA1 P15085 1/20 0.48
▸ ACE2 Q9BYF1 1/20 0.48
▸ TSHR P16473 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ KDM4E B2RXH2 2/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ FDFT1 P37268 2/20 0.47
▸ PTGES O14684 1/20 0.46
▸ FFAR1 O14842 2/20 0.45
▸ TAAR1 Q96RJ0 2/20 0.45
▸ PPARG P37231 1/20 0.45
▸ PPARA Q07869 1/20 0.45
▸ CETP P11597 2/20 0.45
▸ HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23085168 0.90 CETP (0.50) ALDH1A1SMN1; SMN2LMNAMMEACE
SCHEMBL23095167 0.85 LTA4H (0.49) ALDH1A1SMN1; SMN2LMNAMMEACE
SCHEMBL14402644 0.83 CETP (0.55) ALDH1A1SMN1; SMN2LMNAMMEACE
SCHEMBL13850049 0.83 CETP (0.55) ALDH1A1SMN1; SMN2LMNAMMEACE
SCHEMBL9810853 0.83 PTGES (0.50) ALDH1A1SMN1; SMN2MMEACECPA1
SCHEMBL9810886 0.83 FDFT1 (0.48) ALDH1A1SMN1; SMN2MMEACECPA1
SCHEMBL8174800 0.82 CETP (0.54) ALDH1A1SMN1; SMN2MMEACECPA1
SCHEMBL24098463 0.80 TAAR1 (0.69) MMEACECPA1ACE2FDFT1
SCHEMBL30116724 0.80 TAAR1 (0.69) MMEACECPA1ACE2FDFT1
SCHEMBL28973673 0.80 TAAR1 (0.69) MMEACECPA1ACE2FDFT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210386065-A1 MIXTURE OF MECTINS AND PYRETHROIDS AND USES THEREOF VALENT BIOSCIENCES LLC 2021-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210386065-A1 MIXTURE OF MECTINS AND PYRETHROIDS AND USES THEREOF ACHE, DDT, PTMS ALDH1A1 4548/4885SMN1; SMN2 3522/4885LMNA 3932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback